
Value of simultaneous amplification and testing in early diagnosis of Mycoplasma pneumoniae pneumonia and related influencing factors
CHEN Dan, SUN Xiao-Min, GUO Ming-Fa, GUO Qing, ZHANG Guang-Chao, REN Yan-Hong
Chinese Journal of Contemporary Pediatrics ›› 2018, Vol. 20 ›› Issue (9) : 737-741.
Value of simultaneous amplification and testing in early diagnosis of Mycoplasma pneumoniae pneumonia and related influencing factors
Objective To investigate the value of simultaneous amplification and testing (SAT) in the early diagnosis of Mycoplasma pneumoniae pneumonia (MPP) in children and related influencing factors. Methods A total of 526 children with community-acquired pneumonia who were hospitalized between December 2016 and December 2017 were enrolled. Particle agglutination was used to measure serum Mycoplasma pneumoniae (MP) antibody (MP-Ab). The value of SAT in the diagnosis of MPP was evaluated based on these results. Results Based on the results of serum MP-Ab measurement, 165 children were diagnosed with MPP. MP-SAT had a sensitivity of 90.9% (150/165), a specificity of 97.9% (368/376), and high accuracy (Youden index=0.89) in the diagnosis of MPP, suggesting that there was good consistency between these two methods (Kappa=0.90). The diagnostic sensitivity of MP-SAT in children with a short course of disease was significantly higher than that in children with a long course of disease (P=0.031). The diagnostic sensitivity of MP-SAT was significantly higher than that of single serum MP-Ab measurement (P=0.018), with poor consistency between these two methods (Kappa=0.039). MP-SAT had good consistency with double serum MP-Ab measurement (Kappa=0.91). The multivariate logistic regression analysis showed that course of disease (≥ 7 days) and out-of-hospital macrolide treatment were the main factors influencing the results of MP-SAT (P < 0.05). Conclusions MP-SAT has high value in the early diagnosis of MPP and can effectively cover the shortage of single serum MP-Ab test in the acute stage and thus provide help for early clinical diagnosis. MP-SAT test should be performed in the early stage of the disease (< 7 days) and before the application of macrolide treatment.
Mycoplasma pneumoniae / Simultaneous amplification and testing / Early stage / Diagnosis / Child
[1] Jain S, Williams DJ, Arnold SR, et al. Community-acquired pneumonia requiring hospitalization among U.S. children[J]. N Engl J Med, 2015, 372(9):835-845.
[2] 彭懿, 舒畅, 符州, 等. 儿童社区获得性肺炎1613例病原学特点分析[J]. 中国当代儿科杂志, 2015, 17(11):1193-1199.
[3] 王菲, 尚云晓. 肺炎支原体肺炎发病机制及相关临床问题[J]. 中国实用儿科杂志, 2015, 30(3):184-189.
[4] 中华医学会儿科学分会呼吸学组, 《中华实用儿科临床杂志》编辑委员会. 儿童支原体肺炎诊治专家共识[J]. 中华实用儿科临床杂志, 2015, 30(17):1304-1308.
[5] 顾文婧, 张新星, 陈正荣, 等. 呼吸道吸出物MP-DNA检测对儿童肺炎支原体肺炎诊断的临床意义[J]. 中国当代儿科杂志, 2015, 17(9):937-941.
[6] 冯雪莉, 李勤静, 徐保平, 等. RNA恒温扩增检测技术在儿童肺炎支原体肺炎中的诊断价值评估[J]. 中国实用儿科临床杂志, 2016, 31(16):1222-1225.
[7] Wang L, Feng Z, Zhao M, et al. A comparison study between GeXP-based multiplex-PCR and serology assay for Mycoplasma pneumoniae detection in children with community acquired pneumonia[J]. BMC Infect Dis, 2017, 17(1):518.
[8] Li W, Fang YH, Shen HQ, et al. Evaluation of a real-time method of simultaneous amplification and testing in diagnosis of Mycoplasma pneumoniae infection in children with pneumonia[J]. PLoS One, 2017, 12(5):e0177842.
[9] 张海晴, 黄海滨, 王春颖, 等. RNA恒温扩增实时荧光检测技术在检测脑脊液中结核分枝杆菌的应用[J]. 广东医学, 2017, 38(11):1715-1716.
[10] 张睿, 叶阿里, 孔令君, 等. 临床患者三种性传播疾病分子生物学检测分析[J]. 现代检验医学杂志, 2015, 30(3):107-110.
[11] 曹凌峰, 苏犁云, 董妞妞, 等. 荧光恒温扩增技术检测肠道病毒71型方法的建立与评价[J].检验医学, 2014, 29(11):1115-1119.
[12] 中华医学会儿科学分会呼吸学组, 《中华儿科杂志》编辑委员会. 儿童社区获得性肺炎管理指南(2013修订)(上)[J]. 中华儿科杂志, 2013, 51(10):745-752.
[13] 中华医学会儿科学分会呼吸学组, 《中华实用儿科临床杂志》编辑委员会. 儿童支原体肺炎诊治专家共识[J]. 中华实用儿科临床杂志, 2015, 30(17):1304-1308.
[14] 栗俊杰, 张诗蒙, 李小燕. 肺炎支原体感染的两种不同实验室检测方法分析[J]. 中国实验诊断学, 2017, 21(5):799-801.
[15] 郭丽, 孙琳, 郭琰, 等. 肺炎支原体RNA检测在儿童肺炎支原体肺炎疗效监测中的应用价值[J]. 中国循证儿科杂志, 2016, 33(9):643-645.
[16] 庄严, 栗俊杰, 张诗蒙, 等. 肺炎支原体感染的两种不同实验室检测方法分析[J]. 中国实验诊断学, 2017, 12(5):799-801.
[17] 刘香花, 穆义英, 赵玥, 等. 肺炎支原体DNA检测对儿童肺炎的诊断价值[J]. 中国卫生检验杂志, 2016, 26(22):3248-3249.